Filana Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Filana Therapeutics, Inc. (FLNA) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $4.00 thousand as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2023-02-28
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9.00K.
- 2020-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $18.00K.
- 2020-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $20.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2022-12-31 | $4.00K 10-K · filed 2023-02-28 |
| 2021-12-31 | $9.00K 10-K · filed 2022-03-01 |
| 2020-12-31 | $18.00K 10-K · filed 2021-03-23 |
| 2020-09-30 | $20.00K 10-Q · filed 2020-11-09 |
| 2019-12-31 | $9.00K 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |